Neuropace shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $158k | 15k | 10.31 |
| 2025-06-30 | $170k | 15k | 11.14 |
| 2025-03-31 | $113k | 9.2k | 12.29 |
| 2024-12-31 | $103k | 9.2k | 11.19 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors